(Q34759513)

English

Telmisartan protects against microvascular dysfunction during myocardial ischemia/reperfusion injury by activation of peroxisome proliferator-activated receptor γ.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Telmisartan protects against microvascular dysfunction during myocardial ischemia/reperfusion injury by activation of peroxisome proliferator-activated receptor γ. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

reperfusion injury

1 reference

based on heuristic

inferred from title

author name string

Xiao-Cong Zeng

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Xing-San Li

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Hong Wen

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

5 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

BMC Cardiovascular Disorders

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

The diagnosis and treatment of the no-reflow phenomenon in patients with myocardial infarction undergoing percutaneous coronary intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

Rosiglitazone is cardioprotective in a murine model of myocardial I/R.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

Coronary microvascular reperfusion injury and no-reflow in acute myocardial infarction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

AT1 receptor blockade prevents microvascular dysfunction induced by ischemia/reperfusion injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

Changes in connexin 43, metalloproteinase and tissue inhibitor of metalloproteinase during tachycardia-induced cardiomyopathy in dogs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

Protein measurement with the Folin phenol reagent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

Inflammatory bio-markers and cardiovascular risk prediction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

Pharmacology of AT1-receptor blockers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

The coronary no-reflow phenomenon: a review of mechanisms and therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

Recognition of the importance of embolization in atherosclerotic vascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

Features and outcome of no-reflow after percutaneous coronary intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3679831

7 July 2018

Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

Optimal therapeutic strategies in the setting of post-infarct no reflow: the need for a pathogenetic classification

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-gamma-modulating activity, on nitric oxide bioavailability and atherosclerotic change

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

Modulation of PPAR-gamma by telmisartan protects the heart against myocardial infarction in experimental diabetes

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

Transgenic study of the function of chymase in heart remodeling

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

Oxidative stress causes nuclear factor-kappaB activation in acute hypovolemic hemorrhagic shock

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

Effect of atorvastatin (Lipitor) on myocardial apoptosis and caspase-8 activation following coronary microembolization

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-13-39

21 January 2018

Effect of chronic pretreatment of angiotensin-converting receptor blocker on no-reflow phenomenon in patients with acute myocardial infarction undergoing percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/23738781

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The protective effect of ApolipoproteinA-I on myocardial ischemia-reperfusion injury in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/23738781

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of leukocytes in coronary vascular endothelial injury due to ischemia and reperfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/23738781

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/23738781

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term Outcome of Primary Percutaneous Coronary Intervention vs Prehospital and In-Hospital Thrombolysis for Patients With ST-Elevation Myocardial Infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/23738781

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alternation in the coronary blood flow velocity pattern in patients with no reflow and reperfused acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/23738781

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of E-cadherin, beta-catenin and p120ctn in the pulmonary sclerosing hemangioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23738781

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/23738781

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2261-13-39

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34759513&oldid=2197014617"